Proteome Sciences Share Discussion Threads

[jeffian] 16/1/2023 15:41

This is all rather reminiscent of the 'last tree standing' hullaballoo about TMT which was supposed to release a wave of cash for PRM but actually gained traction extremely slowly and, even today, hardly qualifies PRM as a 'growth stock'. The stages that the Randox stroke test have to go through are, firstly, that it has to get to market, secondly, that it has to gain widespread adoption by the NHS and other healthcare services and, thirdly, that we actually see the cash benefit to PRM. Given that the Randox information is all in the public domain, one might imagine that whatever benefit the market ascribes to it is already in the price.

[goatherd] 16/1/2023 15:33

You still believe that then peverill?

[peverill] 16/1/2023 15:29

And GE's NDA.

[james japp] 16/1/2023 14:08

Dont forget the phone lines in Ireland.

[monte1] 16/1/2023 14:02

Tsunamis notwithstanding natch.

[monte1] 16/1/2023 14:01

Imminently?

[dominiccummings] 16/1/2023 13:59

I think you meant 'infinitely' judging by the goalpost always moving at the speed of light?

[james japp] 16/1/2023 13:56

Indefinitely, surely?

[wasjobber] 16/1/2023 13:47

Most definitely.

[bluemango] 16/1/2023 13:43

The ending, finally, of twenty years of schadenfreude is going to be quite something to behold.

Meanwhile, the wait continues ....

[wasjobber] 16/1/2023 13:39

So why have Randox been demonstrating their Stroke biochip test at various exhibitions around the world, if it's not available soon?

[pools2] 16/1/2023 13:09

wasjobber

Correct.

[wasjobber] 16/1/2023 12:53

The document date is irrelevant, the CE marked Stroke test is being released soon and it includes the GSTPi biomarker for "time of Stroke"

[goatherd] 16/1/2023 12:47

James Japp,

Good point, I had missed that.

I don't think it mentions time from stroke either.

[james japp] 16/1/2023 12:45

September 2019, I note.

[goatherd] 16/1/2023 12:42

Randox stroke flyer



Probably not the most recent - thanks James Japp.

[goatherd] 16/1/2023 12:30

Well Dominic,

My reports come from Randox sales people, and marketing people.

Try looking at the Randox website.

[goatherd] 16/1/2023 12:30

Well Dominic,

My reports come from Randox sales people, and marketing people.

Try looking at the Randox website.

[dominiccummings] 16/1/2023 12:25

That the three of you have heard good reports gives me considerable* confidence.



*not considerable

[monte1] 16/1/2023 12:22

.. and me.

Although, tbf, my information is rather more unreliable - coming, as it does, entirely from avatars on a freebb with a woeful record of reliability.

[goatherd] 16/1/2023 11:50

me too, wasjobber

[wasjobber] 16/1/2023 11:49

I've been reliably told that Randox are receiving huge interest in their Stroke biochip test.

[goatherd] 16/1/2023 11:24

Peverill,

It is a test which tells the clinic exactly how long ago the stroke occurred and whether it was an ischaemic or haemorrhagic stroke.

If it was ischaemic (as around 83% are) and took place less than 4.5 hours ago (which, with a decent ambulance service, is achievable) then a "clot buster" drug can be administered. If given within those conditions then "most" (undefined) people will make a full recovery.

As the test is likely to cost a little less than £100 it would seem remarkable value.

It would also save millions of people from severe disability. (over the years, that is) So I think it should be welcomed by most people.

Randox (which is a private company, awash with money from Covid testing) are taking their time getting a CE test. They may be being incompetent, or simply lazy. They do have an experimental version on the market, but will not release the clinical version (which is where royalties kick in) without the CE test.

I am assured the two tests (research and clinical) are identical.

[peverill] 16/1/2023 10:21

WTF are they doing with it,looking at it.??